[go: up one dir, main page]

BR0308377A - Processo para sìntese de n-aril piperazinas quirais - Google Patents

Processo para sìntese de n-aril piperazinas quirais

Info

Publication number
BR0308377A
BR0308377A BR0308377-2A BR0308377A BR0308377A BR 0308377 A BR0308377 A BR 0308377A BR 0308377 A BR0308377 A BR 0308377A BR 0308377 A BR0308377 A BR 0308377A
Authority
BR
Brazil
Prior art keywords
piperazines
synthesis
chiral
aryl piperazines
aryl
Prior art date
Application number
BR0308377-2A
Other languages
English (en)
Inventor
Gregg Brian Feigelson
Joseph Zeldis
Ivo Jirkovsky
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of BR0308377A publication Critical patent/BR0308377A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/18—Ethylenedioxybenzenes, not substituted on the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)

Abstract

"PROCESSO PARA SìNTESE DE N-ARIL PIPERAZINAS QUIRAIS". A presente invenção refere-se a um processo para formação de N-aril piperazinas com cadeias laterais quirais tendo a estrutura mostrada na fórmula abaixo, e para fabricação de compostos intermediários para as mesmas: Neste processo, quiralidade é introduzida na etapa de formação de anel piperazina e substituição 2-aminopiridila é incorporada via deslocamento. As resultantes piperazinas N,N<39>-dissubstituídas atuam sobre o sistema nervoso central em receptores de 5HT.
BR0308377-2A 2002-03-12 2003-03-10 Processo para sìntese de n-aril piperazinas quirais BR0308377A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36343102P 2002-03-12 2002-03-12
PCT/US2003/007078 WO2003078417A1 (en) 2002-03-12 2003-03-10 Process for synthesizing chiral n-aryl piperazines

Publications (1)

Publication Number Publication Date
BR0308377A true BR0308377A (pt) 2005-01-11

Family

ID=28041762

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0308377-2A BR0308377A (pt) 2002-03-12 2003-03-10 Processo para sìntese de n-aril piperazinas quirais

Country Status (23)

Country Link
US (1) US6713626B2 (pt)
EP (1) EP1483255B1 (pt)
JP (1) JP4391241B2 (pt)
KR (1) KR20040105765A (pt)
CN (2) CN1982307A (pt)
AR (1) AR038930A1 (pt)
AT (1) ATE439356T1 (pt)
AU (1) AU2003220094B2 (pt)
BR (1) BR0308377A (pt)
CA (1) CA2477892C (pt)
CR (1) CR7431A (pt)
DE (1) DE60328756D1 (pt)
EC (1) ECSP045290A (pt)
ES (1) ES2329122T3 (pt)
IL (1) IL163827A0 (pt)
MX (1) MXPA04008729A (pt)
NO (1) NO20044050L (pt)
NZ (1) NZ535168A (pt)
RU (1) RU2315762C2 (pt)
TW (1) TW200403231A (pt)
UA (1) UA79273C2 (pt)
WO (1) WO2003078417A1 (pt)
ZA (1) ZA200408202B (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060223824A1 (en) * 2000-11-28 2006-10-05 Wyeth Serotonergic agents
US20060287335A1 (en) * 2000-11-28 2006-12-21 Wyeth Serotonergic agents for treating sexual dysfunction
EP1408976B3 (en) 2001-07-20 2010-08-25 Psychogenics Inc. Treatment for attention-deficit hyperactivity disorder
US7361773B2 (en) * 2002-03-12 2008-04-22 Wyeth Preparation of N1-(2'-pyridyl)-1,2-propanediamine sulfamic acid and its use in the synthesis of biologically active piperazines
ES2334836T3 (es) * 2002-03-12 2010-03-16 Wyeth Preparacion de 2-((2,3-dihidro-benzo(1,4)dioxin-5-il)-(2-hidroxietil)-amino)-etanol y productos intermedios correspondientes.
US7091349B2 (en) * 2002-03-12 2006-08-15 Wyeth Process for synthesizing N-aryl piperazines with chiral N′-1-[benzoyl(2-pyridyl)amino]-2-propane substitution
AU2003220110B2 (en) * 2002-03-12 2009-04-09 Wyeth Process for making chiral 1,4-disubstituted piperazines
US20070099931A1 (en) * 2004-03-19 2007-05-03 Wyeth Pharmaceutical dosage forms and compositions
US20050209245A1 (en) * 2004-03-19 2005-09-22 Wyeth Process for preparing N-aryl-piperazine derivatives
US20050215561A1 (en) * 2004-03-19 2005-09-29 Krishnendu Ghosh Pharmaceutical dosage forms and compositions
CA2599588A1 (en) * 2005-03-01 2006-09-08 Wyeth Crystalline and amorphous 4-cyano-n{(2r)-2-[4-(2,3-dihydro-benzo[1,4]dioxin-5-yl)-piperazin-1-yl]-propyl}-n-pyridin-2-yl-benzamide hydrochloride
CN117003693B (zh) * 2022-05-05 2026-01-30 四川大学华西医院 一类哌啶衍生物及其制备方法和用途

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0189612B1 (en) 1984-12-21 1992-11-04 Duphar International Research B.V New pharmaceutical compositions having a psychotropic activity
JPH01125357A (ja) 1987-11-06 1989-05-17 Dainippon Pharmaceut Co Ltd トリペプチドの誘導体
AU645681B2 (en) * 1991-05-02 1994-01-20 John Wyeth & Brother Limited Piperazine derivatives
GB9125900D0 (en) * 1991-12-05 1992-02-05 Wyeth John & Brother Ltd Piperazine derivatives
WO1994024115A1 (fr) * 1993-04-16 1994-10-27 Santen Pharmaceutical Co., Ltd. Nouveau derive de piperazine
GB9411099D0 (en) * 1994-06-03 1994-07-27 Wyeth John & Brother Ltd Piperazine derivatives
DE69527787T2 (de) 1994-06-03 2003-01-02 John Wyeth & Brother Ltd., Maidenhead Verfahren und zwischenprodukte zur herstellung von piperazinderivaten
GB9413772D0 (en) * 1994-07-08 1994-08-24 Wyeth John & Brother Ltd 5-HT1A ligands
GB9514901D0 (en) * 1995-07-20 1995-09-20 American Home Prod Piperazine derivatives
ES2185009T3 (es) 1996-04-10 2003-04-16 Merck & Co Inc Antagonistas de alfa y beta 3'.
US6469007B2 (en) 2000-11-28 2002-10-22 Wyeth Serotonergic agents

Also Published As

Publication number Publication date
ECSP045290A (es) 2004-10-26
JP4391241B2 (ja) 2009-12-24
MXPA04008729A (es) 2005-07-13
NZ535168A (en) 2006-03-31
EP1483255A1 (en) 2004-12-08
DE60328756D1 (de) 2009-09-24
AR038930A1 (es) 2005-02-02
NO20044050L (no) 2004-09-24
RU2004130300A (ru) 2005-04-10
CR7431A (es) 2008-07-29
JP2005526775A (ja) 2005-09-08
IL163827A0 (en) 2005-12-18
US20030187265A1 (en) 2003-10-02
AU2003220094A1 (en) 2003-09-29
CA2477892A1 (en) 2003-09-25
CN1304388C (zh) 2007-03-14
ES2329122T3 (es) 2009-11-23
KR20040105765A (ko) 2004-12-16
AU2003220094B2 (en) 2009-04-23
EP1483255B1 (en) 2009-08-12
CN1642936A (zh) 2005-07-20
CA2477892C (en) 2010-11-23
WO2003078417A1 (en) 2003-09-25
UA79273C2 (en) 2007-06-11
ZA200408202B (en) 2007-03-28
US6713626B2 (en) 2004-03-30
CN1982307A (zh) 2007-06-20
ATE439356T1 (de) 2009-08-15
RU2315762C2 (ru) 2008-01-27
TW200403231A (en) 2004-03-01

Similar Documents

Publication Publication Date Title
BR0308377A (pt) Processo para sìntese de n-aril piperazinas quirais
BR0209241A (pt) Processo para preparação de derivados de9-deoxo-9a-aza-9a-homoeritromicina a 4-substituida
BR0212983A (pt) Composto, uso do composto, e, intermediários de sìntese
BR0209580A (pt) Derivados de ciclohexan-1, 4 diamina substituìdos
GT200100160A (es) Derivados 4-fenil-piridina.
BRPI0408347A (pt) derivados de pirimidina
BRPI0500585B8 (pt) processo para a síntese de ivabradina e sais de adição desta com um ácido farmaceuticamente aceitável
UY29919A1 (es) Derivados sustituidos de 3,4-dihidroisoquinolin-1-amino-trifluoroacetato, sus composiciones farmacéuticas y aplicaciones
HN1999000149A (es) Derivados de 4,4-biarilpiperidina
BRPI0513672A (pt) processo aperfeiçoado para a preparação de 2h-1-benzopiran-2metanol, (alfa). (alfa)&#39; [iminobis (metileno)] bis [6-fluoro-3, 4-dihidro, [2r* [r* [r* (s*)]]]], composição farmacêutica, forma t1 amorfa, e processo para a preparação da forma t1 de hidrocloreto de nebivolol
PA8543201A1 (es) DERIVADOS DE DIHIDRO-BENZO [B] [1,4]-DIAZEPIN-2-ONA COMO ANTAGONISTAS I DE mGluR2
AR029821A1 (es) Decahidro-isoquinolinas, un proceso para su preparacion, composiciones farmaceuticas que las comprenden y el uso de las mismas para la fabricacion de un medicamento
BR0013311A (pt) Derivados substituìdos de 1,5-dihidropirrol-2-ona eficazes como antagonistas de receptores nmda para o tratamento de estados de dor
ATE377602T1 (de) Morphinanderivate und ihre medizinische anwendung
BR0312169A (pt) Composto, composição farmacêutica, uso do composto, método para o tratamento de um sujeito afligido por uma condição patológica ou doença suscpetivel de redução por antagonismo de receptores muscarìnicos m3 e produto de combinação
BRPI0416534A (pt) composições multiparticuladas com estabilidade melhorada
BRPI0409002A (pt) pirazóis 1,3,4-substituìdos para uso como antagonistas receptores 5h-t no tratamento de psicoses e distúrbios neurológicos
UY28377A1 (es) Agentes terapeuticos
AR028743A1 (es) DERIVADOS DE N-TRIAZOLILMETIL-PIPERAZINA CON ACCIoN ANTAGONISTA DE RECEPTORES DE NEUROQUININA
BR0308315A (pt) Preparação de ácido n1-(2&#39;-piridil)-1,2-propanodiamina sulfâmico e seu uso na sìntese de piperazinas biologicamente ativas
ATE370147T1 (de) Thiazolopyrimidinderivate und deren verwendung als antagonisten des cx3cr1 rezeptors
ATE427310T1 (de) Kondensierte bicyclische pyrimidinderivate
UY26566A1 (es) Nuevos moduladores alostéricos positivos de receptores de ampa (paarm), procedimientos para su preparación y su utilización como medicamentos.
BRPI0500590A (pt) Processo para a sìntese de compostos de 1,3,4,5-tetraidro-2h-3-benzazepin-2-ona, e aplicação na sìntese de ivabradina e sais de adição desta com um ácido farmaceuticamente aceitável
ATE398614T1 (de) Triazolverbindungen und ihre therapeutische verwendung

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A ANUIDADE(S).

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2116 DE 26/07/2011.